Stock LILY34 ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Eli Lilly and Company Sao Paulo

Equities

LILY34

BRLILYBDR006

Market Closed - Sao Paulo
Other stock markets
 21:10:00 27/06/2024 BST 		5-day change 1st Jan Change
165.9 BRL -0.28% Intraday chart for Eli Lilly and Company +1.13% +77.63%
06-26 Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors CI
06-25 Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases
AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round
AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
PR
Lilly Declares Third-Quarter 2024 Dividend
PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products
PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®
PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks
PR
Lilly announces departure of Anat Ashkenazi, chief financial officer
PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality
AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
AQ
Eli Lilly and : Asco Lilly Oncology Presentation
PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER
AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
PR
Major manufacturing investment to support API production for tirzepatide
AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
AQ
Eli Lilly and : 2015 Global Health Programs Report
PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LILY34 Stock
  5. News Eli Lilly and Company
  6. Press Releases